Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFeng, Helian
dc.contributor.authorGusev, Alexander
dc.contributor.authorPasaniuc, Bogdan
dc.contributor.authorWu, Lang
dc.contributor.authorLong, Jirong
dc.contributor.authorAbu‐full, Zomoroda
dc.contributor.authorBalmaña Gelpí, Judith
dc.contributor.authorDiez Gibert, Orland
dc.date.accessioned2021-10-22T09:04:05Z
dc.date.available2021-10-22T09:04:05Z
dc.date.issued2020-07
dc.identifier.citationFeng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu‐full Z, et al. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Genet Epidemiol. 2020 Jul;44(5):442–468.
dc.identifier.issn1098-2272
dc.identifier.urihttps://hdl.handle.net/11351/6445
dc.descriptionSubtipus de càncer de mama; Gen causal
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesGenetic Epidemiology;44(5)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMama - Càncer - Aspectes genètics
dc.subject.meshBreast Neoplasms
dc.subject.meshGenetic Predisposition to Disease
dc.titleTranscriptome-wide association study of breast cancer risk by estrogen-receptor status
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/gepi.22288
dc.subject.decsneoplasias de la mama
dc.subject.decspredisposición genética a la enfermedad
dc.relation.publishversionhttps://doi.org/10.1002/gepi.22288
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Feng H] Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. [Gusev A] Dana‐Farber Cancer Institute, Boston, Massachusetts. [Pasaniuc B] UCLA Path & Lab Med, Los Angeles, California. [Wu L] Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. [Long J] Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt‐Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. [Abu-full Z] Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Diez O] Hereditary Cancer Genetics Group, Area of Clinical and Molecular Genetics, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid32115800
dc.identifier.wos000517111500001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple